April 2-3, 2019
Katie Strother is vice president, medical education at Cartiva Inc., manufacturer of the first FDA-approved synthetic cartilage. Katie is responsible for strategic marketing and medical education initiatives to support commercialization of Cartiva’s platform technology for a great toe arthritis indication. Prior to her current role, she served as Cartiva’s director of clinical affairs executing the pivotal trial, PMA submission and FDA panel review process. Katie has over 15 years of experience in the medical device industry with relevant experience in new product development, clinical research and commercial launch.
Sessions from Katie Strother:
For a medical device start-up company launching a new product, it is critically important to ensure the product’s launch is successful. The most successful launch strategies are driven heavily by [...]